[ad_1]
Two new RSV vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world’s first approved shots against the common respiratory syncytial virus (RSV). The FDA, which typically follows the committee’s recommendations, is expected to decide on approval in May, ahead of RSV’s typical winter surge.
[ad_2]
[ad_1] The homicide rate in the United States dropped to the lowest it’s been in 75 years, according…
[ad_1] LAS VEGAS (AP) — The yearslong case against six Nevada Republicans who were accused of submitting a…
[ad_1] BATON ROUGE, La. (AP) — A representative for Washington Commanders quarterback Jayden Daniels has told LSU it…
[ad_1] NEW YORK (AP) — President Donald Trump pivoted the nation’s attention back to vaccines this week with…